---
title: "Lily Group: Currently, the production and operation situation is normal, and there is no significant information that should be disclosed but has not been disclosed"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/245654121.md"
description: "Lily Group announced on June 23 that its stock price had deviated by more than 20% over three consecutive trading days from June 19 to June 23, which constitutes an abnormal fluctuation. After verification, the company's production and operation are normal, there have been no significant changes in the internal and external environment, and there is no significant information that should have been disclosed but was not"
datetime: "2025-06-23T08:43:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/245654121.md)
  - [en](https://longbridge.com/en/news/245654121.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/245654121.md)
generator: "portal-rs"
---

# Lily Group: Currently, the production and operation situation is normal, and there is no significant information that should be disclosed but has not been disclosed

On June 23, Lily Group announced that the closing price increase deviation of its stock exceeded 20% cumulatively over three consecutive trading days on June 19, June 20, and June 23, which falls under the category of abnormal stock trading fluctuations according to the relevant provisions of the Shanghai Stock Exchange Listing Rules. After verification, the company's current production and operation situation is normal, and there have been no significant changes in the internal and external operating environment; there are no corrections or supplements needed for the information disclosed by the company previously; the company does not have any significant information that should be disclosed but has not been disclosed

### Related Stocks

- [603823.CN](https://longbridge.com/en/quote/603823.CN.md)

## Related News & Research

- [Ukrainian drones kill several, hit warehouse of Russian online retailer Ozon](https://longbridge.com/en/news/296678295.md)
- [Oncoinvent publishes investor presentation on Radspherin alpha therapy for peritoneal metastases](https://longbridge.com/en/news/296323325.md)
- [APT Medical: H1 2026 revenue and profit rose over 25% year-over-year, with strong growth in core segments](https://longbridge.com/en/news/296363764.md)
- [Sinopec files HKEX next-day disclosure return on share repurchase for cancellation](https://longbridge.com/en/news/296325498.md)
- [Cell C publishes pro forma financials after Comm Equipment Company merger](https://longbridge.com/en/news/296585930.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**